Forthcoming data in colorectal cancer screening could put the company’s liquid biopsy on the market – but it looks like Guardant might get there first.
How long can it be before the total breaches $10bn?
While biotech indices fell, 2021 saw private companies raise the largest amount of venture capital ever.
The entry of non-traditional funders – and the availability of non-traditional exits – has altered medtech, though probably only temporarily.
Private device makers enjoy the biggest quarter for four years – and the average deal is larger than ever.
Biopharma scores a $5bn quarter as another big year builds for venture financing.
Find out where the venture money has been flowing in our new report on biopharma investment trends, free to download now.
The German tech investor Kizoo Ventures is committing €300m of its own cash to biotech start-ups working on rejuvenation and healthy lifespan expansion.